Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii
Open Access
- 15 May 2018
- journal article
- research article
- Published by Taylor & Francis in Virulence
- Vol. 9 (1) , 930-942
Abstract
Acinetobacter baumannii can acquire resistance to colistin via complete loss of lipopolysaccharide (LPS) biosynthesis due to mutations in the lpxA, lpxC and lpxD genes. However, although colistin is increasingly being used for the treatment of multidrug resistant infections, very few A. baumannii clinical isolates develop colistin resistance through loss of LPS biosynthesis. This may suggest that LPS loss affects virulence traits that play a role in the transmission and pathogenesis of A. baumannii. In this study we characterize multiple virulence phenotypes of colistin resistant, LPS-deficient derivatives of the ATCC 19606 strain and five multidrug resistant clinical isolates and their colistin resistant, LPS-deficient derivatives. Our results indicate that LPS loss results in growth defects compared to the parental strain in vitro both in laboratory media and human serum (competition indices of 0.58 and 7.0 × 10−7, respectively) and reduced ability to grow and disseminate in vivo (competition index 6.7 × 10−8). Infection with the LPS-deficient strain resulted in lower serum levels of pro-inflammatory cytokines TNF-α and IL-6 compared to the parent strain, and was less virulent in a mouse model of disseminated sepsis. LPS loss also significantly affected biofilm production, surface motility, growth under iron limitation and susceptibility to multiple disinfectants used in the clinical setting. These results demonstrate that LPS loss has a significant effect on multiple virulence traits, and may provide insight into the low incidence of colistin resistant strains lacking LPS that have been reported in the clinical setting.Keywords
Funding Information
- Consejería de Economía, Ciencia y Empresa of the Junta de Andalucía (CTS, 2027)
- Subprograma Miguel Servet from the Ministerio de Economía y Competitividad of Spain (CPII16/00061)
- Subprograma Sara Borrell (CD14/00014)
- Spanish Network for the Research in Infectious Diseases (REIPI RD06/0008/0000)
This publication has 41 references indexed in Scilit:
- Emergence of Colistin-Resistance in Extremely Drug-Resistant Acinetobacter baumannii Containing a Novel pmrCAB Operon During Colistin Therapy of Wound InfectionsThe Journal of Infectious Diseases, 2013
- Colistin-Resistant, Lipopolysaccharide-Deficient Acinetobacter baumannii Responds to Lipopolysaccharide Loss through Increased Expression of Genes Involved in the Synthesis and Transport of Lipoproteins, Phospholipids, and Poly-β-1,6- N -AcetylglucosamineAntimicrobial Agents and Chemotherapy, 2012
- Phosphoethanolamine Modification of Lipid A in Colistin-Resistant Variants of Acinetobacter baumannii Mediated by the pmrAB Two-Component Regulatory SystemAntimicrobial Agents and Chemotherapy, 2011
- Insertion Sequence IS Aba11 Is Involved in Colistin Resistance and Loss of Lipopolysaccharide in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2011
- Impaired Virulence and In Vivo Fitness of Colistin-Resistant Acinetobacter baumanniiThe Journal of Infectious Diseases, 2011
- Vaccination with Outer Membrane Complexes Elicits Rapid Protective Immunity to Multidrug-Resistant Acinetobacter baumanniiInfection and Immunity, 2011
- Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide ProductionAntimicrobial Agents and Chemotherapy, 2010
- Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component SystemAntimicrobial Agents and Chemotherapy, 2009
- Regulation of Acinetobacter Baumannii Biofilm FormationFuture Microbiology, 2009
- Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecyclineEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006